VARIOUS ORGAN MUCOSA-ASSOCIATED LESIONS IN BEHÇET SYNDROME: A CASE REPORT

Thiên Ân Đỗ , Thị Ngọc Duyên Lê, Văn Đĩnh Nguyễn

Main Article Content

Abstract

Behçet syndrome – a rare chronic vasculitis disorder marked by the emergence of ulcerative signs, particularly in the mucosal area. Recurrence, constant change, and even irreparable organ damage are all possible outcomes of these symptoms in various organs. The medical condition makes the sufferer uncomfortable and exerts a detrimental effect on their emotional and physical well-being. We report a case of a patient with visceral and mucocutaneous complications associated with Behçet disease. For three years, the patient has received numerous examinations and treatments, but no clear cause has been identified. The delay between early symptoms and a verified diagnosis of Behçet's illness is extremely long. Therefore, systemic vasculitis should be considered as a differential diagnosis, especially when symptoms present in numerous organs in daily clinical practice.

Article Details

References

1. Wen-Man Zhao Z-JW, Rui Shi, et al. Environmental factors influencing the risk of ANCA-associated vasculitis. Front Immunol 2022;13:991256.
2. de Menthon M LM, Maldini C, et al. HLA-B51/B5 and the risk of Behçet’ disease: a systematic review and meta-analysis of casecontrol genetic association studies. Arthritis Rheum 2009;61:1287–96.
3. Jennette JC FR, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65(1):1-11.
4. Craven A RJ, Ponte C, et al. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 2013;17(5):619-21.
5. Sunderkötter CH ZB, Chen KR, et al. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol 2018 70(2):171-84.
6. Micheletti RG PC. Management of cutaneous vasculitis. Presse Med 2020;49(3):104033.
7. Verity DH MJ, Ohno S, et al. Behçet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213–20.
8. Nieves Marie Leonardo JM. Behcet's Disease: Is There Geographical Variation? A Review Far from the Silk Road. Int J Rheumatol 2015;2015:945262.
9. Alpsoy E. DL, Onder M., et al. Clinical features and natural course of Behçet's Disease in 661 cases: A multicentre study. The British Journal of Dermatology ; 2007;157:901-06.
10. Blake T et a. Birmingham Behçet’s service: classification of disease and application of the 2014 International Criteria for Behçet’s Disease (ICBD) to a UK cohort. BMC Musculoskelet Disord 2017;18:101.
11. El Hasbani G UI, Jawad S, Jawad ASM. The psychological impact of Behçet's disease. Musculoskeletal Care 2022;20(4):742-57.